IT-Analysis.com
IT-Analysis.com Logo
Business Issues Innovation
Business Issues Channels Enterprise Services SME Technology
Module Header
Louella FernandesLouella Fernandes
Louella Fernandes
11th April - Managed Print Services: Are SMBs Ready?
Louella FernandesLouella Fernandes
Louella Fernandes
11th April - The Managed Print Services (MPS) Opportunity for SMBs
Simon HollowayThe Holloway Angle
Simon Holloway
11th April - Intellinote - capture anything!
David NorfolkThe Norfolk Punt
David Norfolk
11th April - On the road to Morocco
Philip HowardBloor IM Blog
Philip Howard
10th April - Attunity Gold Client

News Release

Ex-ARM CEO East backs Oxehealth's vision for vital sign technology applications
Released: 6th February 2014
Publisher: RealWire

Oxehealth, the spin-out from the University of Oxford’s Institute of Biomedical Engineering, today underlined its intention of delivering on the high growth potential of its non-contact vital signs technology with the appointment of a highly experienced technology innovator: Warren East.

Recently announced CBE recipient, Warren is former ARM CEO, board member of Rolls Royce, De La Rue, Dyson andBT, and winner of Computer Weekly’s UKtech 50 ‘The most influential people in UK IT’.

Warren joins the Oxehealth Advisory Board, bringing with him his knowledge of delivering successful long term innovation and growth strategies in fast moving and competitive technology markets.

As CEO of ARM Holdings, the world's leading semiconductor intellectual property supplier, Warren was a key driver in the development of the technology that lies at the heart of many of today’s advanced digital electronic products. He will bring a breadth of insight and perception to advise on the routes to deliver Oxehealth’s innovative clinical technology, as well as bringing his understanding of the market to develop partnership opportunities.

This new appointment enhances the blend of academia and commercial leadership of Oxehealth. The company delivers patented software solutions that work in the real world and utilise innovative, clinically validated algorithms. Its patented Oxecam clinical technology, developed by world-leading scientist Professor Lionel Tarassenko and backed by IP Group plc., enables a digital camera, tablet or phone to monitor the vital signs of an individual, without the need for physical contact or expensive proprietary equipment.

Warren’s IT business background will be invaluable in Oxehealth’s bid to commercialise its proprietary algorithms by licensing software to established global providers of consumer and clinical health services and products. He joins the Advisory Board at a very exciting time in the product development, with practical clinical studies already completed in the Kidney Unit at Oxford University Hospitals NHS Trust and new studies starting shortly.

“I am delighted to have the opportunity to work with such an exciting start-up and believe my experience with ARM’s partnership and licensing business model combined with the world-class innovation from the University of Oxford’s Institute of Biomedical Engineering will help lead to a successful venture,” said Warren East.

Once credentials have been established in healthcare markets, leveraging clinical evidence and proof points, Oxehealth intends to offer its technology into markets including retail, security, automotive and beyond.

Further Information

RealWire
Samantha Sharp
Service Delivery Executive
Tel: +44 (0)1522 883640
Email: enquires@realwire.com


Related Links:

Advertisement



Published by: IT Analysis Communications Ltd.
T: +44 (0)190 888 0760 | F: +44 (0)190 888 0761
Email: